Clinical Trials
13 trialsNCT06760637 2026-05-19
FourLight-3
Pfizer
Phase 3 Active not recruiting
NCT07187726 2026-05-19
PRE-ACT-01
UNICANCER
Phase NA Recruiting
NCT07062965 2026-05-06
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Pfizer
Phase 3 Recruiting
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT05142358 2026-02-02
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
Case Comprehensive Cancer Center
Phase NA Completed
NCT04481113 2026-01-29
Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer
OHSU Knight Cancer Institute
Phase 1 Completed
NCT05726604 2023-06-09
RD3D4
Central Hospital Saint Quentin
Phase NA Unknown
NCT03012100 2023-01-13
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Academic and Community Cancer Research United
Phase 2 Active not recruiting
NCT04929197 2022-11-08
PERSBRA
Taipei Medical University Hospital
Phase NA Unknown
NCT03459898 2022-05-05
Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing Control
Sunnybrook Health Sciences Centre
Phase NA Completed
NCT03514654 2021-05-18
MIAMI
University College, London
Phase NA Completed
NCT02052102 2017-01-06
Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
AHS Cancer Control Alberta
Phase 2 Unknown
NCT01496001 2015-10-06
Cosmetic and Functional Outcomes After Breast Conserving Surgery
National Institute of Oncology, Hungary
Phase NA Completed